Streetwise Healthcare Services Sponsors
Select a name to see a detailed description, expert analysis and contact information.
|"With several new discovery highlights that GYA may outline in the year ahead, there is a good case to be made for a speculative position in this emerging gold junior."|
|"A U.S. Secretary of the Interior order derisks time risk for PGLC."|
|"INO announced the publication of two preclinical studies of the company's plasmid DNA-encoded monoclonal antibody constructs in treating cancer and preventing infection from a pneumonia-causing bacteria."|
|RP's Phase 1/2a trial for tendon repair in chronic Achilles tendinosis met its goal and established a complete safety profile at six months that showed no serious adverse events."|
|"EFR's potential to grow alternative feed revenue exceeds expectation."|